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CHAPTER I
INTRODUCTION AND BACKGROUND

Carbenes
Defined as neutral, reactive carbons with valences of two and two unshared
valence electrons,1-3 carbenes have been under intensive research in recent years (Figure
1.1). Since this breakthrough, much has been learned about carbenes, and they have been
essential moieties in a broad array of catalyst.

Figure 1.1

Generic depiction of a carbene

Depending upon a carbenes’ spin multiplicity, it will either conform to a singlet or
triplet electronic state, thus determining the molecular geometry (Figure 1.2). Regarding
carbenes in the triplet state, they are capable assuming linear or bent geometries, and the
carbene carbon is either sp or sp2 hybridized. Therefore, carbenes in the triplet state are
energetically more stable, as shown by Hund’s Rule, since the two non-bonding electrons
are in degenerate orbitals (px and py).4

1

Figure 1.2

Orbital depiction of singlet and triplet carbenes

Breaking this linear geometry will also cause the occupied orbitals’ to break their
degeneracy, and the carbene carbon becomes sp2 hybridized (Figure 1.3). In order to
distinguish the degenerate orbitals from the newly generated, energetically inequivalent
orbitals, the py orbital is referred to as the p orbital, and the px orbital, which becomes
stabilized by adapting more “s” character, is now called the  orbital. If the energy
required to place the electrons in the same orbital is greater than the energy difference
between the two orbitals, the carbene will be a triplet carbene. Contrastingly, if the
energy required to place the electrons in the same orbital is less than the difference in
energy of the two orbitals, the resulting carbene will be a singlet carbene. Singlet
carbenes are sp2 hybridized, thus resulting in them also adopting a bent geometry.
Because singlet carbenes possess both filled and vacant orbitals, it is expected that they
are each capable of displaying either nucleophilic or electrophilic reactivity in organic
reactions. This characteristic elucidates their versatility and ensuing usefulness.

2

Figure 1.3

Energy diagram of linear and bent carbenes

The ground state multiplicity of a carbon is important since it directly affects the
carbene’s reactivity.5 Inductive effects, steric effects, and mesomeric effects of the
substituents bonded to the carbene carbon play a role in determining the carbene’s ground
state multiplicity. For example, research has shown that the ground state multiplicity of a
carbene is capable of being altered from the triplet state to the singlet state by exchanging
the carbene carbon’s substituents.6,7 The singlet state is favored when the substituents are
-electron withdrawing, which is attributed to the -electron withdrawing substituents
inductively stabilizing the  non-bonded orbital’s “s” character and lowering its energy.
The decrease in energy of the  non-bonding orbital results in a greater p- energy gap,
and the singlet electron state becomes favored. As expected, when the substituents are electron donating, the p- energy gap is decreased; the triplet state is favored.

3

Triplet carbenes are typically understood to be far more reactive than their singlet
carbene analogues, because in reactions, the structural features of these carbenes require
the carbene to go through a diradical intermediate, which limits it to participation in stepwise radical reaction pathways. Singlet carbenes, however, react in a concerted manner.
This concerted mechanistic reactivity has been observed in the reaction of alkenes with
carbenes to form cyclopropanes (Figure 1.4).8 Singlet carbenes will form only one
stereospecific product while triplet carbens will yield diastereomeric products. The work
discussed herein has utilized N-heterocycles as precursors to N-heterocylic carbene
(NHC) moieties due to all NHCs possessing the singlet ground state multiplicity.

Figure 1.4

Reaction of carbene with alkenes

4

N-heterocyclic Carbenes (NHCs)
Even though NHCs were first synthesized by Öfele and Wanzlik in the 1960’s,9,10
it was not until 1988 that Bertrand et. al. published the first stable carbene.11 Furthermore,
Arduengo did not publish the first crystal structure of a free carbene, which was an NHC,
until 1991 (Figure 1.5).12 Originally, stability of NHCs was attributed to the bulky
adamantyl groups bound to the nitrogens of the N-heterocycle, but after the publication of
a methyl substituted NHC crystal structure, it has been accepted that the stability stems
from the lone pairs of the nitrogen atoms being capable of donating into the vacant p
orbital of the carbene carbon.13 Furthermore, NHC stability is increased by the nitrogens’
electron withdrawing effects, which stabilize the non-bonding electrons in the  orbital of
the carbene (Figure 1.6). Consequently, NHCs are more stable than other carbene species.

Figure 1.5

First isolated carbenes by Arduengo

Figure 1.6

Electronic configuration of NHCs
5

The result of NHCs’ lack of dissociation, neutral charge, and -donating ability,
has led them to be considered phosphine compliments, even though they are stonger donors than even the strongest phosphine analogues,14 and omnipresent in late-transition
metal complexes.15 These transition metal complexes have been shown to catalyze a wide
range of transformations such as olefin metathesis,16 C-C coupling,17 and
hydrosilylation.18
Evidence suggest that the catalytic activity of transition metal complexes
employing NHC moieties can be enhanced by adding aryl substituents to nitrogens in Nheterocycles.19 Until recently, there was not a methodology that would allow for the
efficient, direct synthesis of N-heterocycles with aryl-substituted nitrogens, which are salt
precursors to NHCs. In 2002 Yoshida and Kunai reported a methodology where
nucleophilic attack on aryne intermediates by 1-alkyl imidazoles yielded 1-alkyl-3-aryl
imidazolium salts (Figure 1.7).20 Unfortunately, our attempts to utilize this method for bis
N-heterocyclic systems did not yield the desired bis-arylated product. Fortunatley, Gao
and You recently reported a methodology that utilizes hypervalent iodonium salts as
electrophilic arylation reagents for this purpose (Figure 1.8).21 Their report represented a
significant advance and should prove a useful tool for the synthesis of a wide range of
unsymmetrical imidazolium salts for NHC precursors. The extension of their
methodology to di-imidazolium systems is discussed herein and provides easy access to
arylated CCC-NHC pincer ligand precursors.
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Figure 1.7

Methodology of Yoshida and Kunai

Figure 1.8

Methodology of Gao and You

Although imidazolium derived NHCs constitute the majority of NHC research,
triazolium-based NHCs, C-4 or C-5 bound carbenes, also known as “abnormal carbenes”
or mesoionic carbenes, and anionic N-heterocyclic dicarbenes (NHDC) are noteworthy
variants (Figure 1.9).22-24 Abnormal NHCs (aNHCs), which are discussed later in this
work, have been shown experimentally and theoretically to be stronger donors than their
C2 coordinated equivalents.25-30 They are often referred to as mesoionic carbenes to
describe an NHC ring system where one must assign formal positive or negative charges,
and a resonance structure with all neutral formal charges does not exist. Bertrand only
recently reported the first crystal structure of a free aNHC.22 Transition metal complexes
utilizing aNHC ligands have expanded the scope of transformations catalyzed by
imidazolium-derived NHCs and demonstrate greater reactivity in comparison to the C2
coordinated imidazolium NHCs.30-32
7

Figure 1.9

NHC and NHC Variants

Pincer Ligands
Pincer ligands were first reported by Shaw in 1976,33 and have since become an
important class of ligands for transition metal complexes. The unique steric and
electronic tunability of pincer ligands has resulted in pincer-transition metal complexes
being exploited as catalysts for a multitude of transformations, including
dehydrogenation,34-40 C-C41-44 and C-N45-50 bond formation. The general architecture of a
pincer ligand is a central, often aromatic, donor group with two lateral donor groups on
each side of the central donor group (Figure 1.10). Pincer ligands have achieved
widespread use due to the capability of varying the lateral donor groups. This provides an
effective way to alter the properties of the metal center. Accordingly, incorporation of
NHCs into pincer ligands has become of increasing interest.

8

Figure 1.10

General structure of a pincer complex

CCC-NHC pincer ligands
As of now, there are four major classes of CCC-NHC pincer ligand architectures
incorporating NHCs (Figure 1.11); however, this is likely to change as methodologies for
synthesizing unsymmetrical pincer ligands that preferentially coordinate through the C-4
or C-5 carbons of the N-heterocyclic ring continue to be developed. Currently, the four
major classes can be broken down through the consideration of two structural details. The
first identifying characteristic is the atomic identity of the aryl, central atom donor,
typically either carbon or nitrogen. The second identifying trait is whether there is a
methylene spacer between the aryl and lateral NHC donors. Type B bis(NHC) pincer
ligand in figure 1.11 represents the pioneering work of The Hollis Group, and researchers
around the world have continued to expand this research.51
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Figure 1.11

Metal complexes derived from CCC-NHC pincer ligands

The first step in the synthesis of The Hollis Group CCC-NHC pincer complex is
the coupling of an N-heterocycle to dibromo-substituted benzene, usually in a 2:1 molar
ratio for 48h (Figure 1.12).51 Modification of the reaction’s molar ratio and reaction time
has lead to the development of unsymmetrical CCC-NHC pincer ligand complexes
(Figure 1.13). Additionally, by cleverly choosing a C-2 substituted imidazolium
derivative as one of the N-heterocycles to be coupled to the dibromobenzene, a
methodology for the synthesis of mixed, unsymmetrical CCC-NHC pincer ligands was
developed. This unsymmetrical ligand features an aNHC, and transition metal complexes
utilizing aNHC ligands have expanded the scope of transformations catalyzed by
imidazolium-derived NHCs. Moreover, these aNHCs demonstrate greater reactivity in
comparison to the C2 coordinated imidazolium NHCs.32
10

Figure 1.12

Traditional synthesis of 1,3-bis(N-heterocyclic)benzenes

Figure 1.13

Modified synthesis of 1,3-bis(N-heterocyclic)benzenes

Conventionally, the second step in The Hollis Group’s synthesis of CCC-NHC
pincer complexes is to activate the imidazolium proton by adding alkyl groups to the N-3
position of the N-heterocycle. Aiming to increase the architectural diversity of CCCNHC pincer ligands, the previously mentioned methodology of Gao and You was
employed to add aryl groups to the N-3 position instead of alkyl groups (Figure 1.4).21
The capacity to generate bis-1,3-(3-Aryl-N-heterocycl-1-yl)arenes will provide easy
access to NHC based pincer ligand precursors, and evidence from some catalytic systems
suggest that the presence of an aryl substituent, in lieu of an alkyl substituent, improves
11

pincer catalyst performance in dehydrogenation.52 The results of these experiments are
discussed in further detail in chapter 2.

Figure 1.14

Arylation of 1,3-bis(N-heterocyclic)benzene

Early-transition metal amido starting materials have proved to be effective in
triple C-H bond activation of ligand precursors via amine elimination.53 This
methodology exploits the d0 metal center, in conjunction with the basicity of the
dimethylamido ligands to achieve the triple C-H activation and has consequently resulted
in a facile route for the synthesis of group 4 CCC-NHC pincer complexes. Furthermore,
the additional ligands coordinating to the metal center can be varied depending on the
amount of Zr(NMe2)4 starting material used. For example, excess Zr(NMe2)4 yielded
CCC-NHC bis(dimethylamido)iodo Zr (Figure 1.15), while using stoichiometric amounts
of freshly sublimed Zr(NMe2)4 yielded CCC-NHC (dimethylamido)bis(iodo) Zr complex
(Figure 1.16).
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Figure 1.15

Triple C-H bond activation of CCC-NHC ligand precursor

Figure 1.16

Stoichiometric synthesis of CCC-NHC group 4 metal complexes

The work herein focuses on the extension of CCC-NHC ligand precursor
methodologies and application of newly reported methodologies in order to diversify
CCC-NHC ligand architectures. Specifically, the previously reported methodology of
Gao and You should lead to the efficient synthesis of diverse arylated CCC-NHC pincer
complexes. Additionally, the methodology for developing mixed, unsymmetrical pincer
complexes opens up the door for a multitude of structurally diverse CCC-NHC pincer
complexes to be developed with severely varying properties. These next generation
catalyst developed from these architectures should prove useful in catalyzing a broad
array of transformations not previously accessible through the four standard CCC-NHC
pincer ligand architectures

13

CHAPTER II
EFFICICENT SYNTHESIS OF BIS-1,3-(3’-ARYL-N-HETEROCYCL-1’-YL)ARENES
AS CCC-NHC PINCER LIGAND PRECURSORS

Reprinted in part with permission from Howell, T. O.; Huckaba, A. J.; Hollis, T. K.
Organic Letters 2014. Copyright 2014 American Chemical Society.
Research Background
The vast majority of reports for the synthesis of unsymmetrical N, N-diaryl
imidazolium salts follow Arduengo’s original multi-step aryl N-heterocyclic carbene
(NHC) synthetic protocol.54-57 After searching sometime for an efficient, direct synthesis
to unsymmetrical N, N-diaryl imidazolium salts we had exhausted all the known, direct
methodologies. Fortunatley, Gao and You recently reported a methodology that utilizes
hypervalent iodonium salts as electrophilic arylation reagents for this purpose (Scheme
1).58 Their report represented a significant advance and should prove a useful tool for the
synthesis of a wide range of unsymmetrical imidazolium salts for ionic liquid59 and NHC
precursors.60 The extension of their methodology to di-imidazolium systems is reported
herein and provides easy access to arylated CCC-NHC pincer ligand precursors.

14

Figure 2.1

Methodology of Gao and You

Several methodologies for synthesizing unsymmetrical aryl imidazolium salts
have been reported in the last decade.61-67 As Yoshida and Kunai reported in 2002,
nucleophilic attack on aryne intermediates by 1-alkyl imidazoles yielded 1-alkyl-3-aryl
imidazolium salts (Scheme 2).68 Unfortunately, our attempts to utilize this method for the
arylation of 1,3-di-N-imidazolylbenzene, 1, did not yield the desired bis-arylated product.
Therefore, methods that afford bis-1,3-(3-Aryl-N-heterocycl-1-yl)arenes were needed.

Figure 2.2

Methodology of Yoshida and Kunai

The capacity to generate bis-1,3-(3-Aryl-N-heterocycl-1-yl)arenes will provide
easy access to NHC based pincer ligand precursors. Recently, NHCs have been
incorporated into tridentate meridional pincer ligands since they are stronger electron
donors than phosphine analogues, which lends to higher activity for some complexes.44,6972

Since they were first reported by Shaw in 1976, pincer ligands have become an
15

important moiety in transition metal complexes.73-76 Furthermore, evidence from some
catalytic systems suggest that the presence of an aryl substituent, in lieu of an alkyl
substituent, improves pincer catalyst performance in dehydrogenation.19
The strategy presented by Gao and You was employed to produce bis(N, N-diaryl
N-heterocyclic) salts for CCC-NHC pincer ligand precursors. Additionally, preliminary
metallation of the bis-1,3-(3-Aryl-N-heterocycl-1-yl)benzene ligand precursor with
Zr(NMe2)4 and transmetalation using [Pt(COD)Cl2] is discussed.
Results and Discussion
All bis-imidazole and bis-triazole starting materials were synthesized according to
previous methodology. Preliminary arylation experiments of 1 with bis(phenyl)iodonium
tetrafluoroborate catalyzed with Cu(OAc)2H2O or CuO in d6-DMSO were monitored by
1H NMR spectroscopy, which indicated that the reaction was successful in yielding the
desired product and complete in 2h. Attempts to scale up the reaction with reagent grade
DMSO were unsuccessful, as arylated DMSO was the only product observed. This sideproduct was attributed to trace amounts of DMS, thus DMF was chosen as the solvent for
scaled-up arylations. These reactions were monitored by mass spectrometry, and at 2h the
reaction was complete. A mass spectrum of 2 contained a peak at m/z 451 that
corresponded to ([M-BF4]+, calcd for C24H20BF4N4+ 451), and the 1H NMR spectrum
contained an imidazolium proton resonance at δ 10.35.
To examine the effects of electron withdrawing or donating groups and steric
congestion, the arylation of 1 was attempted with bis conjugated-aryl iodonium salts
(Figure 2.3). For the preparation of 3, 1 was reacted with bis(4-t-butylphenyl)iodonium
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salt and monitored via thin layer chromatography (TLC). After 20h, the reagents had
been converted to product as shown TLC. Product 3 was isolated, and the 1H NMR
spectrum contained an imidazolium proton resonance at δ 10.43. Next, 4 was prepared
from the reaction of 1 with bis(4-fluorophenyl)iodonium salt, and within 20h the reagents
had again been converted into product as shown by TLC. Compound 4 was isolated, and
the 1H NMR spectrum contained a resonance at δ 10.47. The preparation of 3 and 4
indicated that electron withdrawing and donating groups do not significantly impact the
conversion of reactants to products. However, the increased reaction time is indicative of
the transformation regiospecificity being similar to that observed by Gao and You, in
which sterics are the governing factor in reaction rate.

Figure 2.3

Isolated yields of varying bis(imidazolium)salts

Because it had been shown that when unsymmetrical iodonium salts are employed
for arylation the least substituted aryl group is selectively transferred, [3(trifluoromethyl)phenyl](2,4,6-trimethylphenyl)iodonium salt was reacted with 1 to
further investigate the impact of steric congestion. TLC was used to monitor the reaction,
and after 23h, starting material was no longer present. However, 5 was not observed as
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the product upon isolation. Further studies are underway to probe the reactivity of
unsymmetrical iodonium salts.
Once the synthesis and isolation of 2, 3 and 4 had been optimized, the aim
became to define the scope of this methodology within bis(N-heterocyclic) systems
(Figure 2.4). Arylation products 6, 7, 8 and 9 were obtained using the reaction conditions
shown in figure 2.3, and each reaction was run in an NMR tube using d6-DMSO as the
solvent. 1H NMR spectroscopy was utilized to determine conversion. The bis(Nheterocyclic) compounds were converted into N, N-diaryl N-heterocyclic salts within
16h, and although isolation of the desired products proved challenging, isolated yields
were obtained, thus supporting the application of this methodology to other bis(Nheterocyclic) systems. The 1H NMR spectrum of each contained the expected
imidazolium proton resonance in the down field region (6, δ 11.68; 7, δ 10.27; 8, δ 10.74;
9, δ 10.47).

Figure 2.4
a

The scope of N-heterocyclic reactivity with [Ph2I]+[BF4]-

isolated yields and bconversion
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Now that arylated CCC-NHC pincer precursors were available, metalation
became a priority. Attempts to metalate 2 with Zr(NMe2)4 proved to be challenging,
which was attributed to the insolubility of 2. Therefore, 3 was utilized since it contained
t-butyl groups that improved solubility. Compound 3 was successfully metalated with
excess Zr(NMe2)4 as shown by 1H NMR spectroscopy. Metalation occurred within 30
min using methylene chloride as the solvent as indicated by the loss of an imidazolium
proton resonance, δ 10.43, in the 1H NMR spectrum. Additionally, the 13C NMR
spectrum contained a signal at  190.19 that corresponded to an NHC carbon bound to
Zr. Addition of [Pt(COD)Cl2] yielded an air-stable CCC-NHC pincer complex, 10
(Figure 2.5), and the crude 1H NMR spectrum continued to show a loss of three aromatic
protons compared to salt 3. Furthermore, the 13C NMR spectrum contained a carbonmetal bond resonance shift from  190.19 to  170.43, which signifies a NHC carbon
bound to Pt.

Figure 2.5

Synthesis of Pt CCC-NHC pincer complex

Conclusions
In conclusion, a variety of bis(N, N-diaryl N-heterocyclic) salts have been
synthesized utilizing a methodology recently reported by Gao and You. This extension
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provides efficient access to potential ionic liquids and pincer ligand precursors.
Additionally, metalation of 3 with Zr(NMe2)4 and transmetallation using [Pt(COD)Cl2]
yielded a Pt CCC-NHC pincer complex, 10, in a total of three isolation steps starting with
1,3-dibromobenzene. This synthetic transformation represents an important step forward
in efficicent access to di-aryl imidazolium salts.
Experimental Section for Complexes
General details
All commercial reagents were purchased from Sigma Aldrich and used as
received. NMR spectra were obtained from either a 300 MHz or 600 MHz Bruker
instrument and referenced to residual protio-solvent peaks (1H and 13C). High-resolution
mass spectra (HRMS) were acquired using electro-spray ionization technique on a Bruker
instrument. Low-resolution mass spectra (MS) were acquired using chemical ionization
technique with a direct insertion probe on a Shimadzu instrument. All reactions were
carried out under inert atmospheric conditions. Thin layer chromatography (TLC) was
carried out using glass plates coated with a 250 m layer of 60 Å silica gel. TLC plates
were visualized via staining with iodine. Solutions were concentrated under reduced
pressure. All N, N-diaryl imidazolium salts were used as received with the exception of
diphenyliodonium tetrafluoroborate, which was synthesized according to a previously
reported methodology.
1,1'-(1,3-phenylene)bis(3-phenyl-1H-imidazol-3-ium) tetrafluoroborate, 2; 1,3bis(imidazol-1'-yl) benzene (0.59 g, 2.80 mmol) was reacted with diphenyliodonium
tetrafluoroborate (2.75 g, 9.80 mmol) and copper (II) acetate (3.6 mg, 0.02 mmol) in
DMF at 130 C. After 2 h the reaction was removed from the heat and passed through
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Celite. Volatiles were removed under reduced pressure resulting in brown oil. CH2Cl2
was added to the oil causing a white precipitate (1.00 g, 100%) that was removed via
filtration. The precipitate was shown to be product by 1H NMR spectroscopy, 13C NMR
spectroscopy, and HRMS. 1H NMR (300 MHz, DMSO)  10.45 (t, J = 6.0, 2H),  8.67
(dd, J = 6.0, 18.0, 4H),  8.50 (t, J = 6.0, 1H),  8.20 (d, J = 7.8, 2H),  8.09 (t, J = 7.5,
1H),  7.93 (d, J = 7.5, 4H),  7.74 (m, 6H); 13C (600 MHz, DMSO)  135.66, 135.19,
134.84, 134.82, 134.56, 132.09, 123.01, 122.33 (d, J = 30.0), 122.09, 121.74 (d, J =
30.0), 115.63 (d, J = 18.0); HRMS (ESI/CH2Cl2) m/z calcd for C24H20B1F4N4+ (M –
BF4)+ 450.1638, found 450.1619.
1,1'-(1,3-phenylene)bis(3-(4-(tert-butyl)phenyl)-1H-imidazol-3-ium)
trifluoromethanesulfonate, 3; 1,3-bis(imidazol-1'-yl) benzene (63.2 mg, 0.30 mmol) was
reacted with bis(4-tert-butylphenyl)iodonium trifluoromethanesulfonate (804.1 mg, 1.47
mmol) and copper (II) acetate (4.3 mg, 0.02 mmol) in DMF at 130 C. After 20 h the
reaction was removed from the heat and passed through Celite. Volatiles were removed
under reduced pressure resulting in brown oil. A 75 mL silica column was slurry-packed
using a 20:1 CH2Cl2:MeOH solution as the solvent. 15 fractions (25 mL) were collected
before switching to a 10:1 CH2Cl2:MeOH solvent and 15 more 25 mL fractions were
collected. A light brown powder was isolated from fractions 22-26. This powder was
dissolved in CH2Cl2 and silica dissolved by the methanol was removed via filtration.
Volatiles were removed from the filtrate resulting in a brown powder (160 mg, 70%)The
brown powder was shown to be product by 1H NMR spectroscopy, 13C NMR
spectroscopy, and HRMS. 1H NMR (600 MHz, DMSO)  10.43 (s, 2H),  8.65 (t, J =
6.0, 4H),  8.51 (s, 1H),  8.21 (dd, J = 6.0, 12.0, 2H),  8.09 (t, J = 12.0, 1H),  7.86 (d,
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J = 6.0, 4H),  7.76 (d, J = 6.0, 4H),  1.37 (d, J = 6.0, 18H); 13C (600 MHz, DMSO) 
152.91, 135.40, 134.76 (q, J = 222.0), 131.92 (d, J = 78.0), 126.76, 122.72, 122.13 (d, J =
24.0), 121.56, 121.42 (d, J = 30.0), 119.28, 115.43 (d, J = 24.0), 34.44, 30.96; HRMS
(ESI/CH2Cl2) m/z calcd for C33H36F3N4O3S+ (M – OTf)+ 625.2445, found 625.2281.
1,1'-(1,3-phenylene)bis(3-(4-fluorophenyl)-1H-imidazol-3-ium)
trifluoromethanesulfonate, 4; 1,3-bis(imidazol-1'-yl) benzene (64.0 mg, 0.30 mmol) was
reacted with bis(4-fluorophenyl)iodonium triflate (703.3 mg, 1.50 mmol) and copper (II)
acetate (4.6 mg, 0.02 mmol) in DMF at 130 C. After 20 h the reaction was removed
from the heat and passed through Celite. Volatiles were removed under reduced pressure
resulting in dark oil. A 75 mL silica column was slurry-packed using a 20:1
CH2Cl2:MeOH solution as the solvent, and after 14 fractions that were 25 mL each had
been collected, a 10:1 CH2Cl2:MeOH solution was used as the solvent. 25 fractions (25
mL) were collected, and a brown solid was isolated from fractions 17 and 18. The brown
solid was dissolved in CH2Cl2, and silica previously dissolved by methanol was removed
via filtration. Volatiles were removed yielding a brown solid (141 mg, 67%), that was
spectroscopically pure. 1H NMR (300 MHz, DMSO)  10.43 (t, J = 6.0, 2H),  8.64 (dd,
J = 6.0, 12.0, 4H),  8.48 (t, J = 6.0, 1H),  8.20 (d, J = 6.0, 1H),  8.19 (d, J = 6.0, 1H),
 8.10 (t, J = 6.0, 1H)  8.00 (m, 4H),  7.65 (m, 4H); 13C (600 MHz, DMSO) 163.39,
161.75, 135.68 (d, J = 210.0), 132.17, 131.05 (d, J = 12.0), 124.80 (d, J = 42.0), 122.96
(d, J = 186.0), 121.73 (d, J = 78.0), 119.60, 117.17 (J = 96.0), 115.52; HRMS
(ESI/CH2Cl2) m/z calcd for C25H19F5N4O3S+ (M – OTf)+ 550.1093, found 550.0807.
Attempted Synthesis of 1,1'-(1,3-phenylene)bis(3-(3-(trifluoromethyl)phenyl)-1Himidazol-3-ium) trifluoromethanesulfonate, 5; 1,3-bis(imidazol-1'-yl) benzene (66.0 mg,
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0.30 mmol) was reacted with [3-(trifluoromethyl)phenyl](2,4,6trimethylphenyl)iodonium trifluoromethanesulfonate (766.7 mg, 1.39 mmol) and copper
(II) acetate (4.6 mg, 0.02 mmol) in DMF at 130 C. After 23 h the reaction was removed
from the heat and passed through Celite. Volatiles were removed under reduced pressure
resulting in brown oil. A 75 mL silica column was slurry-packed using a 100:1
CH2Cl2:MeOH solution as the solvent. After 100 mL of 100:1 methylene
chloride:methanol solution, 100 mL of 50:1 CH2Cl2:MeOHsolution was used. This was
followed by 100 mL of 20:1 CH2Cl2:MeOH. 30 fractions about 25 mL in volume were
collected and a light brown was isolated from fractions 27 and 28 (154 mg, 64%). 1H
NMR spectroscopy, 13C NMR spectroscopy, and HRMS suggested that multiple aryl
imidazolium salts had formed.
1,1'-(1,3-phenylene)bis(4-phenyl-1H-1,2,4-triazol-4-ium) tetrafluoroborate, 6;
1,3-bis(triazol-1'-yl) benzene (0.22 g, 0.93 mmol) was reacted with diphenyliodonium
tetrafluoroborate (1.32 g, 4.65 mmol) and copper (II) acetate (9.2 mg, 0.05 mmol) in
DMF at 130 C. After 24 h the reaction was removed from the heat and passed through
Celite. Volatiles were removed under reduced pressure resulting in light-yellow oil.
CH2Cl2was added to the oil causing a precipitant to form that was removed via filtration.
The precipitate was recrystalized using 1.5 mL DMSO, 5 mL of hexanes and 20 mL
CH2Cl2. The isolated tan solid (70.0 mg, 14%) was shown to be pure product by 1H NMR
spectroscopy, 13C NMR spectroscopy, and HRMS. 1H NMR (300 MHz, DMSO)  11.64
(s, 2H),  10.09 (s, 2H),  8.70 (s, 1H),  8.33 (dd, J = 6.0, 7.5, 2H),  8.14 (t, J = 18.0,
1H),  7.95 (d, J = 18.0, 4H), 7.81 (m, 6H); 13C (600 MHz, DMSO) 143.50 (d, J =
90.0), 141.61 (d, J = 114.0), 136.09, 132.46, 132.00 (d, J = 24.0), 130.94, 130.37 (d, J =
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30.0), 122.55 (d, J = 24.0), 122.30, 112.89;; HRMS (ESI/DI) m/z calcd for C22H18BF4N6+
(M + MeCN)+ 581.1920, found 581.5628.
1,1'-(1,2-phenylene)bis(3-phenyl-1H-imidazol-3-ium) tetrafluoroborate, 7; 1,2bis(imidazol-1'-yl) benzene (0.20 g, 0.93 mmol) was reacted with diphenyliodonium
tetrafluoroborate (1.35 g, 4.65 mmol) and copper (II) acetate (12.2 mg, 0.05 mmol) in
DMF at 130 C. After 24 h the reaction was removed from the heat and passed through
Celite. Volatiles were removed under reduced pressure resulting in dark-brown oil.
CH2Cl2 was added to the oil causing a precipitate to form that was removed via filtration.
The precipitate was recrystalized using 1.5 mL DMSO, 5 mL of hexanes and 20 mL
CH2Cl2. The isolated purple powder (283.7 mg, 57%) was shown to be pure product by
1

H NMR spectroscopy, 13C NMR spectroscopy, and HRMS. 1H NMR (300 MHz,

DMSO)  10.27 (t, J = 6.0, 2H),  8.52 (t, J = 6.0, 2H),  8.11 (m, 4H),  8.05 (m, 2H), 
7.86 (dd, J = 6.0, 4H),  7.73 (m, 4H), 7.67 (m, 2H); 13C (600 MHz, DMSO) 137.66,
137.51, 134.27, 132.25, 130.17 (d, J = 18.0), 128.85, 128.32, 123.46, 121.84 (d, J =
12.0), 121.67; HRMS (ESI/CH2Cl2) m/z calcd for C24H20BF4N4+ (M – BF4)+ 451.1716,
found 451.1550.
1,1'-(1,3-phenylene)bis(3-phenyl-1H-benzo[d]imidazol-3-ium) tetrafluoroborate,
8; 1,3-Bis(benzimidazol-1'-yl) benzene (0.27 g, 0.80 mmol) was reacted with
diphenyliodonium tetrafluoroborate (0.90 g, 4.00 mmol) and copper (II) acetate (10.3 mg,
0.04 mmol) in DMF at 130 C. After 14 h the reaction was removed from the heat and
passed through Celite. Volatiles were removed under reduced pressure resulting in dark
oil. CH2Cl2 was added to the oil causing a white precipitate (139.7 mg, 28%) that was
removed via filtration. The precipitant was shown to be pure product by 1H NMR
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spectroscopy, 13C NMR spectroscopy, and HRMS. 1H NMR (300 MHz, DMSO)  10.74
(s, 2H),  8.58 (t, J = 6.0, 1H),  8.25 (m, 5H),  8.01 (m, 6H),  87.83 (m, 10H); 13C
(600 MHz, DMSO)  143.46, 143.13, 134.26, 132.86, 132.71, 131.17, 130.96, 130.59,
128.10, 128.03, 127.59, 125.33, 122.13, 114.01, 113.94; HRMS (ESI/CH2Cl2) m/z calcd
for C32H23BF4N4+ (M – BF4 )+ 551.2030, found 551.1623.
1,1'-(1,4-phenylene)bis(3-phenyl-1H-imidazol-3-ium) tetrafluoroborate, 9; 1,4bis(imidazol-1'-yl) benzene (0.21 g, 0.93 mmol) was reacted with diphenyliodonium
tetrafluoroborate (1.31 g, 4.65 mmol) and copper (II) acetate (9.7 mg, 0.05 mmol) in
DMF at 130 C. After 24 h the reaction was removed from the heat and passed through
Celite. Volatiles were removed under reduced pressure resulting in light-yellow oil.
CH2Cl2 was added to the oil causing a precipitant to form that was removed via filtration.
The grey powder isolated (0.43 g, 86%) was shown to be pure product by 1H NMR
spectroscopy, 13C NMR spectroscopy, and HRMS 1H NMR (300 MHz, DMSO)  10.47
(t, J = 6.0, 2H),  8.68 (dd, J = 6.0, 24.0, 4H),  8.28 (d, J = 24.0, 4H),  7.94 (dd, J =
12.0, 18.0, 4H),  7.71 (m, 6H); 13C (600 MHz, DMSO) 135.55, 135.35, 135.05, 134.92,
134.61, 130.27 (t, J = 12.0), 123.51, 122.12 (d, J = 12.0), 121.84; HRMS (ESI/CH2Cl2)
m/z calcd for C24H20BF4N4+ (M – BF4)+ 451.1716, found 451.1550.
2-(1,3-Bis(3'-p-tertbutylphenyl-imidazol-2' ylidene)phenylene) (dimethylamido)
triflate zirconium (IV); In a glovebox a dry NMR tube was charged with 1,1'-(1,3phenylene)bis(3-(4-(tert-butyl)phenyl)-1H-imidazol-3-ium) trifluoromethanesulfonate
(6.0 mg,7.75 mol), Zr(NMe2)4 (5.8 mg, 38.75 mol), and 0.5 mL of deuterated CH2Cl2.
After 30 min the key spectroscopic data suggest the formation of product. Key 1H NMR
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data (600 MHz, CD2Cl2)  7.86 (d, J =6.0, 2H),  7.60 (dd, J = 6.0, 4H),  7.52 (m, 3H),
 7.43 (dd, J = 6.0, 6.0, 4H),  7.40 (d, J = 12.0, 2H)  1.04 (s, 18H); Key 13C data (600
MHz, CD2Cl2)  190.19, 153.19, 148.59, 137.32, 131.66, 127.25, 127.13, 123.42, 122.90,
117.28, 112.07.
2-(1,3-Bis(3'-p-tertbutylphenyl-imidazol-2'-ylidene)phenylene)(chloro) platinum
(II); To a dry screw cap NMR tube was added 1,1'-(1,3-phenylene)bis(3-(4-(tertbutyl)phenyl)-1H-imidazol-3-ium) trifluoromethanesulfonate (6.0 mg, 7.8 mol),
Zr(NMe2)4 (5.8 mg, 38.8 mol) and 1.0 mL of methylene chloride. After 30 min at rt the
1

H NMR indicated the formation of a pincer complex as indicated by the absence of three

aromatic protons. This was followed by the addition of Pt(COD)Cl2 (3.5 mg, 9.3 μmol),
which was allowed to react for 18h. The key spectroscopic data is reported and suggest
the formation of product. Key 1H NMR data (600 MHz, CD2Cl2)  7.73 (d, J = 6.0, 2H),
 7.64 (dd, J = 6.0, 6.0, 4H),  7.48 (dd, J = 6.0, 6.0, 4H),  7.35 (t, J = 12.0, 1H),  7.26
(d, J = 6.0, 2H),  7.18 (d, J = 6.0, 2H); Key 13C data (600 MHz, CD2Cl2)  172.54,
157.59, 147.44, 137.97, 134.14, 131.22, 129.71, 129.50, 128.35, 126.54, 118.92 (t, J =
84.0, 195Pt satellites), 111.46. HRMS (ESI/CH2Cl2) m/z calcd for C33H36N5Pt+ (M –
NCH3 )+ 697.2616, found 697.2452; m/z calcd for C32H33N4Pt+ (M – Ligand )+ 668.2350,
found 668.2520.
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CHAPTER III
A METHOD FOR THE SYNTHESIS OF MIXED, UNSYMMETRICAL (CCC-NHETEROCYCLIC CARBENE) PINCER PROLLIGAND COMPLEXES
FEATURING NHC/ABNORMAL NHC LIGANDS

Introduction
In recent years the development of tridentate meridional “pincer” ligand
complexes featuring N-heterocyclic carbene (NHC) moieties has suffered from a lack of
synthetic methodologies. Pincer ligands were first reported by Shaw in 1976, and have
since become an important class of ligands for transition metal complexes.73-76 The
unique steric and electronic tunability of pincer ligands has resulted in pincer-transition
metal complexes being exploited as catalysts for a multitude of transformations,
including dehydrogenation,34-40 C-C41-44 and C-N45-50 bond formation.
NHCs have also become recognized as remarkable transition metal ligands since
their isolation by Arduengo et. al. in 1991.12 This is attributed to NHCs being stronger
donors than even the strongest phosphine analogues, thus constructing a transition metalNHC complex with improved stability, catalytic reactivity, and selectivity.44,69-72 As the
synthetic utility of NHCs has unfurled, the coordination of imidazolium-derived NHCs
via the C2 carbon has become recognized as “normal.” Therefore, when the coordination
of an imidazolium-derived NHC was found to occur through the C5 carbon it was
deemed an “abnormal” NHC (aNHC) ligand.23,24 Further investigations, experimental
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and theoretical, have found aNHC ligands to be stronger donors than their C2
coordinated equivalents.25-30 Transition metal complexes utilizing aNHC ligands have
expanded the scope of transformations catalyzed by imidazolium-derived NHCs and
demonstrate greater reactivity in comparison to the C2 coordinated imidazolium NHCs.3032,77

In 2011, Braunstein et. al. fortuitously synthesized a CCC-NHC featuring mixed
NHC/aNHC coordination (Scheme 1).32 The work herein aimed to develop a
methodology allowing for the direct synthesis of a CCC-NHC pincer with aNHC/NHC
coordination and applies this methodology to design unsymmetrical CCC-NHC ligands.
These discoveries should allow for the evolution of unique CCC-NHC pincer
architectures.

Figure 3.1

Synthesis of NHC/aNHC by Braunstein

A method for the efficient synthesis of unsymmetrical CCC-NHC pincer
complexes featuring mixed NHC/aNHC ligands in four isolation steps is reported herein.
Additionally, the resulting catalyst is probed for reactivity in the catalytic conduction of
hydroamination transformations.
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Results and Discussion
Ligand synthesis
Synthesis of the unsymmetrical, mixed NHC/aNHC pincer ligand precursor
proceeded through multiple pathways. Each pathway begin by reacting a triazole,
imidazole, or C2 substituted imidazolium derivative with 1,3-dibromobenzene, 1, in order
to generate 2, 3, 4, or 5 (Scheme 2). The progress of each reaction was monitored via thin
layer chromatography (TLC), and it was determined the sterically congested imidazolium
derivatives required longer reaction times. TLC observed no starting material present in
the synthesis of 2 and 5 after 12 h, but the synthesis of 3 required 24 h for reactants to be
converted into products. Additionally, the complete conversion of starting materials to
products was never observed in the synthesis of 4. The conversion of reactants to
products was further investigated by monitoring the synthesis of 3 via GC/MS (Figure 1).
The formation of 3 was found to become competitive with the formation of 1,3-bis(2methylinidazol-1-yl)benzene after 22 h. This information aided in the acquisition of
higher yields, and provided insight into the rate of conversion for the syntheses of 2, 4,
and 5 as well.

Figure 3.2

Synthesis of mono(N-heterocyclic) substituted benzenes
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Figure 3.3

Conversion of reactants to products in the synthesis of 3 as shown by
GC/MS

Due to the facile isolation and synthesis of 2 and 5, subsequent reactions for the
synthesis of an unsymmetrical, mixed NHC/aNHC proceeded through the reaction of 2 or
5 with a C2 substituted imidazolium derivative (Scheme 3). As expected, longer reaction
times were required for the sterically congested imidazolium moieties to add to 2 and 5.
Upon isolation of the intermediates 5 and 6, X-ray crystals were grown from the
evaporation of methylene chloride from a product-containing sample.
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Figure 3.4

Addition of second N-heterocycle

Figure 3.5

ORTEP diagram of 6

Figure 3.6

ORTEP diagram of 7

Alkylation of 6 with excess butyl iodide in a sealed flask at 110 C for 16 h
yielded 9 (Scheme 4). The 1H NMR spectrum of 9 contained a singlet at  11.10
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corresponding to the imidazolium proton, and triplets were observed at  4.47 (J1 = 7.20
Hz, J2 = 7.50 Hz) and  4.20 (J1 = 7.50 Hz, J2 = 7.50 Hz) corresponding to the methylene
groups  to the nitrogens. The 13C NMR spectrum contained a peak at  145.0 that
corresponds to the imidazolium carbon and peaks at  132.3 and  127.5 corresponding to
the C-4 and C-5 carbons of the conjugated N-heterocycle. A mass spectrum of the
product contained peaks at m/z 465.1524 ([M - I]+, calcd for C21H30N4I 465.1510). These
data were indicative of the synthesis of 9. The 1H NMR spectrum of 10 contained a
singlet at  9.87 corresponding to the imidazolium proton and triplets at  4.27 (J1 = 7.20
Hz, J2 = 6.90 Hz) and  4.12 (J1 = 7.20 Hz, J2 = 6.90 Hz) corresponding to the methylene
groups  to the nitrogen atoms. The 13C NMR spectrum contained a peak at  144.4 that
corresponds to the imidazolium carbon and peaks at  132.4 and  131.2 corresponding to
the C-4 and C-5 carbons of the conjugated N-heterocycle. A mass spectrum of the
product contained peaks at m/z 527.1723 ([M-I]+, calcd for C26H32N4I 527.1666). These
data were indicative of the synthesis of 10. Finally, the 1H NMR spectrum of 11
contained a resonance at  10.97 corresponding to the imidazolium proton and triplets at

 4.32 (J1 = 7.20 Hz, J2 = 7.80 Hz) and  4.09 (J1 = 7.20 Hz, J2 = 7.20 Hz) corresponding
to the methylene groups  to the nitrogen atoms. The 13C NMR spectrum contained a
peak at  145.21 that corresponds to the C-2 imidazolium carbon and peaks at  132.3
and  131.3 corresponding to the C-4 and C-5 carbons of the conjugated N-heterocycle.
A mass spectrum of the product contained peaks at m/z 527.1806 ([M-I]+, calcd for
C25H30N5I 527.1540). These data suggest the synthesis of 11.
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Figure 3.7

Synthesis of CCC-NHC ligand precursors

Metalation: Zr
Similar to the previously reported procedures for Zr metalation,78 compounds 9,
10 and 11 were initially reacted with excess Zr(NMe2)4 in dichloromethane. Preliminary
results indicated that the metalation of 9 did not yield the desired pincer ligand, and
further experiments are being conducted. However, metalation of 10 (Scheme 5) resulted
in the synthesis of ((1-(3-butylimidazol), 3-(3-butyl(2-phenylimidazol))-1-yl-2-idene)-2
phenylene)mono(dimethylamine)-bisiodozirconium (IV) (12). The most palpable
alteration from the 1H NMR spectrum of 10 after treatment with Zr(NMe2)4 was the loss
of an imidazolium proton signal at  9.87. Furthermore, the signals corresponding to the
butyl methylene groups  to the nitrogen atoms shifted from triplets at  4.27 and  4.12
to triplets at  4.17 and  3.77 in 12. In the 13C NMR spectrum the carbene peaks can be
observed at  196.3 and  174.3, which are also indicative of successful CCC-NHC
pincer complex. Additionally, an aryl peak can be seen at  170.2, thus indicating the
formation of the Zr-C(aryl) bond. These data are supportive of the formation of 12. The
preliminary data for the metalation of 11 contains no imidazolium proton resonance at 
10.97, which suggest a pincer complex has been generated. However, multiple
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coordination spheres appear to be present in solution, and further characterization is
being performed.

Figure 3.8

Synthesis of CCC-NHC Zr complex

Hydroamination catalytic activity
Complex 12 was investigated for hydroamination activity against 2,2diphenylhex-5-en-1-amine (entry 1) and 2,2-diphenylpent-4-en-1-amine (entry 2). The
results of this experiment are summarized in Table 1. The catalytic reactions were
conducted inside a sealed NMR tube at 160 C with deuterated toluene serving as the
solvent, and 1H NMR spectroscopy was used to monitor each reaction. As expected, the
synthesis of the six-member ring required longer reaction times for significant conversion
to occur. The reactivity of this complex is still under investigation.
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Table 3.1

Hydroamination catalytic activity of 8

Conclusions
The reported methodology yields a next generation unsymmetrical CCC-NHC
pincer ligand featuring mixed NHC/aNHC in four isolation steps, thus expanding the
potential for innovative CCC-NHC pincer complex design. Furthermore, it has been
shown that this methodology is not only limited to imidazolium derived NHCs, but
triazolium systems as well. Finally, preliminary data suggest these complexes are
capable of assisting in catalytic transformations, thus broadening the scope of their
application. These advancements should allow for greater diversification in the
architectural designs of CCC-NHC pincer complexes, and further research to expand the
application of this methodology, as well as, evaluate the reactivity of transition-metal
complexes is underway.
Experimental Section
General considerations
Reactions were performed under atmospheric conditions unless stated otherwise.
All starting materials were purchased from Sigma Aldrich and used as received with the
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exception of tetrakis(dimethylamido)zirconium(IV), which was purified by sublimation
under reduced pressure. Toluene, DMSO, and CH2Cl2 were passed through columns of
activated alumina. CD2Cl2 and toluene-d8 were purchased from Cambridge Isotopes and
passed through a column of activated basic alumina. DMSO-d6 was purchased from
Cambridge Isotopes and used as received. 1H and 13C NMR spectra were collected on a
Bruker Avance 300 MHz or a Bruker Avance 600 MHz NMR spectrometer at ambient
temperatures. The 1H NMR spectra were referenced internally from the residual protio
solvent signal: CD2Cl2 (δ 5.32), DMSO-d6 (δ 2.50), or toluene-d8 (δ 2.09). The 13C NMR
spectra were referenced internally using the signal from the deuterated solvent: CD2Cl2 (δ
54.0), DMSO-d6 (δ 39.51), and toluene-d8 (δ 20.4).
Preparation of 1-(3-bromophenyl)-1H-imidazole; Imidazole (9.20 g, 135.14
mmol), 1,3-dibromobenzene (31.88 g, 135.14 mmol), CuO (3.22 g, 40.54 mmol), K2CO3
(44.82 g, 324.33 mmol), and 175 mL of DMSO were combined in a round bottom flask
and heated for 24 h at 150 C. The reaction mixture was cooled to room temperature and
passed through 30 g of basic alumina. Volatiles were then removed under reduced
pressure and the resulting solid was passed through a basic alumina column. Et2O (700
mL) was used to separate the product from the starting material. Yellow oil (11.27 g,
50.77 mmol) remained after removing volatiles from the first five fractions (100 mL).
The yellow oil was shown to be product by 1H NMR spectroscopy, 13C NMR
spectroscopy, and HRMS. 1H NMR (600 MHz, DMSO)  8.34 (s, 1H),  7.92 (t, J = 1.8,
1H),  7.79 (s, 1H),  7.65 (dd, J1 = 0.6, J2 = 5.5, 1H),  7.48 (dd, J1 = 0.6, J2 = 1.2, 1H),
 7.41 (t, J = 16.2, 1H),  7.13 (s, 1H); 13C (300 MHz, DMSO)  138.59,  135.45, 
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131.20,  130.58,  130.27,  124.39,  123.15,  119.96,  118.01; HRMS (ESI/CH2Cl2)
m/z calcd for C9H8N2Br+ (M)+ 222.9865, found 222.9927.
Preparation of 1-(3-bromophenyl)-2-methyl-1H-imidazole; 2-methylimidazole
(1.33 g, 16.15 mmol), 1,3-dibromobenzene (3.81 g, 16.15 mmol), CuO (0.30 g, 3.77
mmol), K2CO3 (0.64 g, 4.63 mmol), and 30 mL DMSO were heated for 92 h at 150 C.
The reaction was cooled to room temperature and diluted with 200 mL CH2Cl2. Neutral
alumina (150 g) was added to a 500 mL column, and the reaction mixture was dried onto
Celite under reduced pressure. After adding the Celite onto the column, the column was
eluted with 500 mL of CH2Cl2. The volatiles were removed under reduced pressure
awarding yellow tinted powder (0.54 g, 2.27 mmol). The 1H NMR spectrum, 13C NMR
spectrum, and MS are all consistent with the light yellow powder being pure product. 1H
NMR (300 MHz, CDCl3)  7.60 (d, J = 7.8, 1H),  7.50 (s, 1H),  7.39 (t, J = 7.8, 1H), 
7.29 (d, J = 9.3, 1H),  7.05 (d, J = 11.7, 2H)  2.40 (s, 3H); 13C NMR (300 MHz,
CDCl3)  144.58,  139.23,  131.27,  130.69,  128.67,  128.10,  124.17,  122.87, 
120.43,  13.78, MS m/z calcd for C10H10N2Br+ (M+H)+ 236.9, found 236.9.
Attempted Preparation of 1-(3-bromophenyl)-2-phenyl-1H-imidazole; 2phenylimidazole (1.45 g, 10.02 mmol), 1,3-dibromobenzene (2.84 g, 12.02 mmol), CuO
(0.24 g, 3.00 mmol), K2CO3 (3.32 g, 24.05 mmol), and 20 mL DMSO were heated for 72
h at 150 C. The reaction was cooled to room temperature and diluted with 100 mL
CH2Cl2. The diluted solution is passed through a plug of basic alumina (150 g). Volatiles
were removed resulting in black oil precipitating out of solution. Multiple products were
thought to be in the oil after evaluation via 1H NMR spectroscopy. Further investigation
is ongoing.
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Preparation of 1-(3-bromophenyl)-1H-1,2,4-triazole; 1,3-dibromobenzene (9.48g,
40.17 mmol) was reacted with triazole (2.79g, 40.17 mmol), CuO (0.34g, 12.06
mmol),and K2CO3 (13.35g, 96.42 mmol) in 75 mL of DMSO at 150 C for 24 h. The
reaction mixture was added onto a basic alumina plug, and the plug was eluted with
CH2Cl2. The elutant (150 mL) was collected and passed through 30 g plugs of basic
alumina two more times. After removing volatiles a white powder (2.22g, 25%) was
isolated and shown pure by 1H NMR and 13C NMR. 1H NMR (600 MHz, DMSO): 
8.57 (s, 1H);  8.07 (s, 1H);  7.92 (s, 1H);  7.65 (dd, J1= 2.4, J2= 10.2, 1H);  7.54 (dd,
J1= 1.2, J2= 10.8, 1H);  7.40 (t, J= 16.2, 1H) 13C NMR (600 MHz, DMSO):  152.61, 
142.78,  137.89 (d, J= 120),  131.69,  130.43,  122.35,  121.83,  118.28 (d, J=54);
MS m/z calcd for C8H7N3Br+ (M+H)+ 223.9, found 223.8.
Preparation of 1-(3-(1H-imidazol-1-yl)phenyl)-2-phenyl-1H-imidazole; 1-(3bromophenyl)-1H-imidazole (3.00g, 13.51 mmol) was reacted with 2-phenylimidazole
(2.34g, 16.21 mmol) at 150 C for 72 h. After the reaction had cooled to room
temperature, it was passed through a plug of basic alumina and volatiles were removed
under reduced pressure. A silica column was slurry packed using 10:1 EtOAc:IPA and
300 mL of this solution was used to collect 30 fractions (25 mL). The silica column was
then eluted with IPA. Fractions 26-IPA elution were collected, and volatiles were
removed yielding a brown powder (0.88g, 13.51 mmol) that was shown to be product by
1

H NMR, 13C NMR, and HRMS. 1H NMR (600 MHz, DMSO):  8.32 (s, 1H);  7.79 (s,

2H);  7.50 (d, J= 8.4, 1H);  7.62 (s, 1H);  7.54 (t, J = 8.4, 1H);  7.38 (d, J = 3.0, 2H);
 7.32 (d, J= 2.4, 3H);  7.22 (s, 1H);  7.13 (t, J= 8.4, 2H); 13C NMR (600 MHz,
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DMSO):  145.76,  139.30,  137.63,  130.80,  130.28,  130.13,  128.76,  128.26
(d, J= 54),  124.13,  123.74,  119.51,  117.93,  117.49; HRMS (ESI/CH2Cl2) m/z
calcd for C18H15N4+ (M+H)+ 287.1291, found 287.1372.
Preparation of 1-(3-(2-phenyl-1 H-imidazol-1-yl)phenyl)-1H-1,2,4,-triazole; 1-(3bromophenyl)-1H-1,2,4-triazole (1.00 g, 4.46 mmol), 2-phenylimidazole (0.77 g, 5.35
mmol), CuO (0.11 g, 1.33 mmol), K2CO3 (1.48 g, 10.70 mmol), and 20 mL of DMSO
were combined in a round bottom flask and heated for 48 h at 150 C. The reaction
mixture was cooled to room temperature and passed through a plug of basic alumina (30
g). Volatiles were then removed under reduced pressure and the resulting solid was
subjected to a silica column. EtOAc (700 mL) was used to separate the product from the
starting material. Voaltiles were removed from the elutant yielding a light yellow powder
(0.26g, 0.90 mmol) that was shown to be product by 1H NMR, 13C NMR, and HRMS. 1H
NMR (300 MHz, CD2Cl2):  8.47 (s, 1H);  8.05 (s, 1H);  7.71 (dd, J1= 1.8, J2 = 6.3,
1H);  7.62 (t, J=1.8 1H);  7.54 (t, J = 7.8, 1H); 7.42 (m, 2H);  7.26 (m, 6H); 13C NMR
(600 MHz, DMSO):  152.76 (2C),  146.70,  141.08,  139.91,  137.87,  130.80, 
130.30,  129.34,  128.67,  128.52,  128.27,  125.26,  122.70,  119.04,  117.31;
HRMS (ESI/CH2Cl2) m/z calcd for C17H15N5+ (M+H)+ 288.1244, found 288.1329.
Preparation of 1-(3-(1H-imidazol-1-yl)phenyl)-2-methyl-1H-imidazole; 1-(3bromophenyl)-2-methyl-1H-imidazole (0.60 g, 2.52 mmol), imidazole (0.21 g, 3.02
mmol), CuO (0.06 g, 0.76 mmol), K2CO3 (0.84 g, 6.05 mmol), and 3.5 mL of DMSO
were combined in a round bottom flask and heated for 48 h at 150 C. The reaction
mixture was cooled to room temperature and diluted with CH2Cl2 (50 mL). The reaction
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was dried onto Celite and placed onto a plug of neutral alumina (75 g). The plug was
eluted with CH2Cl2 (200 mL) followed by IPA (200 mL). Volatiles were then removed
from the 200 mL of IPA under reduced pressure, and the resulting yellow powder (0.18 g,
0.80 mmol) that was shown to be product by 1H NMR, 13C NMR, and HRMS. 1H NMR
(300 MHz, CD2Cl2):  7.89 (s, 1H);  7.62 (t, J= 8.1, 1H);  7.50 (dd, J1= 1.2, J2 = 6.0,
1H);  7.38 (m, 3H);  7.18 (s, 1H);  7.08 (d, J=1.22, 1H);  6.99 (d, J= 1.2, 1H)  2.37
(s, 3H); 13C NMR (300 MHz, DMSO):  144.61,  139.53,  138.39,  135.50,  131.57,
 131.34,  131.09,  130.74,  128.70,  128.31,  128.06,  124.35,  124.21,  120.87,
 120.48,  120.25,  118.50,  118.04,  114.61,  13.88; MS m/z calcd for C17H15N5+
(M+H)+ 225.11, found 225.0.
Preparation of 4-butyl-1-(3-(3-butyl-2-phenyl-1H-imidazol-3-ium-1-yl)phenyl)1H-1,2,4-triazol-4-ium; 1-(3-bromophenyl)-1H-1,2,4-triazole(0.75g, 2.62 mmol) was
reacted with butyl iodide (2.43g, 26.20 mmol) in a sealed reaction vessel at 160 C for 24
h after purging the flask with argon. After the reaction had cooled to room temperature,
volatiles were removed yielding an oil. Crystalization was performed on the oil using
CH2Cl2:Et2O causing a light orange solid (30.0 mg, 14%) to precipitate out of solution.
This was shown product by 1H NMR spectroscopy, 13C NMR, and HRMS. 1H NMR (600
MHz, DMSO):  11.05 (s, 1H);  8.96 (s, 1H);  8.30 (t, 1H, J= 1.8);  8.07 (d, J= 1.2,
1H);  7.96 (d, J = 2.4, 1H);  7.80 (d, J = 2.4, 1H);  7.65 (m, 4H);  7.53 (m, 3H); 
4.40 (t, J = 7.5, 2H);  4.10 (t, J= 7.5, 2H);  2.01 (m, 2H);  1.83 (m, 2H);  1.44 (m,
2H);  1.33 (m, 2H);  0.99 (t, J = 7.5, 2H);  0.85 (t, J= 7.2, 2H); 13C NMR (600 MHz,
DMSO)  145.21,  144.54,  142.20,  136.20,  135.44,  132.32,  131.30,  130.98, 
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129.24,  128.39,  123.90,  122.56,  121.89,  121.15,  119.06,  48.18,  47.90, 
31.08,  30.47,  18.80,  18.70,  13.33,  13.19; HRMS (ESI/CH2Cl2) m/z calcd for
C25H30N5I+ (M-I-H)+ 527.1540, found 527.1806.
Preparation of 3-butyl-1-(3-(3-butyl-1H-imidazol-3-ium-1-yl)phenyl)-2-phenyl1H-imidazol-3-ium; 1-(3-(1H-imidazol-1-yl)phenyl)-2-phenyl-1H-imidazole (2.00 g,
7.01 mmol) was reacted with butyliodide (12.90 g, 70.1 mmol) in a storage flask at 150
C for 48 hours. After the reaction mixture had cooled and volatiles had been removed
under reduced pressure, a burnt orange solid (5.16 g) was collected. The solid was rinsed
with dichloromethane that had been cooled in a dry ice/acetone bath yielding a white
solid (3.02 g, 82%) . 1H-NMR (600 MHz, DMSO)  9.96 (s, 1H),  8.32 (d, J= 20.4, 4H),
 8.12 (s, 1H),  7.95 (d, J= 7.8, 1H),  7.70 (m, 3H),  7.63 (t, J=7.2, 1H),  7.57 (m,
3H),  4.29 (t, J=6.6, 2H) ,  4.12 (t, J=7.2, 2H),  1.89 (t, J=7.2, 2H),  1.74 (t, J= 7.2,
2H),  1.33 (q, J= 7.2, 2H),  1.23 (q, J=7.2, 2H),  0.93 (t, J=7.8, 3H),  0.78 (t, J=7.8,
3H); 13C-NMR (600 MHz, DMSO)  144.29,  135.82,  135.62,  135.50,  135.08, 
132.32,  131.05,  129.23,  127.36,  123.81,  123.63,  123.27,  122.61,  120.98, 
120.78,  120.40,  49.27,  48.20,  30.99,  30.95,  18.78,  18.67,  13.29,  13.11;
HRMS (ESI/CH2Cl2) m/z calcd for C26H32N4I+ (M-I)+ 527.1666, found 527.1723.
Preparation of 3-butyl-1-(3-(3-butyl-1H-imidazole-3-ium-1-yl)phenyl)-2-methyl1H-imidazole-3-ium; 1-(3-(1H-imidazole-1-yl)phenyl)-2-methyl-1H-imidazole (0.35 g,
1.56 mmol), 1-iodobutane (2.88 g, 15.6 mmol), and MeCN (4 mL) were combined in a
25 mL storage flask and heated at 110 C for 72 hours. The reaction was cooled to room
temperature and diluted with 20 mL MeCN. Volatiles were removed yielding orange oil.
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This oil was dissolved in 15 mL MeCN and white solid (0.56 g, 61% yield) was
precipitated out with Et2O. The solid was removed by filtration through a fine frit. 1H
NMR (300 MHz, CD2Cl2)  11.09 (s, 1H),  9.03 (s, 1H),  8.53 (s, 1H),  8.39 (d, J=
6.6, 1H),  7.85 (m, 3H),  7.59 (d, J= 25.8, 2H),  4.47 (t, J= 7.2, 2H),  4.20 (t, J=7.5,
2H),  2.00 (m, 2H),  1.47 (m, 2H),  1.00 (m, 6H); 13C NMR (300 MHz, CD2Cl2) 
145.02,  135.74,  135.65,  135.52,  132.32,  127.45,  124.28,  123.04,  122.97, 
121.77,  121.62,  121.48,  50.45,  49.45,  31.91,  31.26,  19.84,  19.48,  13.29,
 13.25; HRMS (ESI/CH2Cl2) m/z calcd for C26H32N4I+ (M-I)+ 465.1510, found
465.1524.
Preparation of ((1-(3-butylimidazol),3-(3-butyl(2-phenylimidazol))-1-yl-2-idene)2-phenylene)mono(dimethylamine)-bisiodozirconium (IV); In a glove box, 3-butyl-1-(3(3-butyl-1H-imidazol-3-ium-1-yl)phenyl)-2-phenyl-1H-imidazol-3-ium (297.0 mg, 0.74
mmol) was combined with Zr(NMe2)4 (112.2 mg, 0.75 mmol) and 18.5 mL anhydrous
toluene. The reaction was heated at 140 C overnight. When the reaction was cooled to
room temperature at white, microcrystalline solid (179.0 mg, 36%) precipitated out of
solution and was removed via filtration. The crystalline solid was identified as product
using 1H NMR and 13C NMR spectroscopy. 1H-NMR (300 MHz, DMSO)  7.70 (m, 3H),
 7.64 (d, J=1.8, 1H),  7.52 (m, 2H),  7.25 (d, J=1.5, 1H),  7.20 (d, J=7.8, 1H), 7.11
(s, 1H),  7.03 (t, J=7.8, 1H),  6.21 (m, 1H),  4.06 (t, J=7.2, 2H),  3.80 (t, J=7.2, 2H),
 1.74 (m, 4H),  1.33 (m, 4H),  1.04 (t, J=7.2, 3H),  0.89 (t, J=7.5, 3H); 13C-NMR
(300 MHz, DMSO)  170.18,  151.18,  138.24,  132.91,  130.80 (t, J=63.6), 
129.48,  129.14,  128.82,  128.55,  128.23,  127.91,  127.63,  125.47 (d, J=50.1),
42

 125.01 (d, J=94.5),  122.91,  116.44,  114.27,  111.58,  51.99,  47.69,  39.47, 
38.97,  34.01,  32.79,  14.17,  13.92.
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APPENDIX A
SPECTROCOPIC DATA FOR CHAPTER II COMPOUNDS

49

Figure A.1

HRMS of 2

Theoretical, bottom m/z calcd for C24H20B1F4N4+ (M – BF4)+ 450.1638; Experimental,
top found 450.1619
50

Figure A.2

HRMS of 3

Theoretical, bottom m/z calcd for C33H36F3N4O3S+ (M – OTf)+ 625.2455; Experimental,
top found 625.2281
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Figure A.3

HRMS of 4

Theoretical, top m/z calcd for C25H18F5N4O3S+ (M – OTf)+ 550.1093; Experimental,
bottom found 550.0807

52

Figure A.4

HRMS of 6

Theoretical, bottom m/z calcd for C22H18BF4N6+ (M + MeCN)+ 581.1920; Experimental,
top found 581.5628
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Figure A.5

HRMS of 7

Theoretical, bottom m/z calcd for C24H20BF4N4+ (M – BF4)+ 451.1716; Experimental, top
found 451.1550
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Figure A.6

HRMS of 8

Theoretical, bottom m/z calcd for C32H23BF4N4+ (M – BF4 )+ 551.2030; Experimental, top
found 551.1623
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Figure A.7

HRMS of 9

Theoretical, bottom m/z calcd for C24H20BF4N4+ (M – BF4)+ 451.1716; Experimental, top
found 451.1550
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Figure A.8

HRMS of Pt CCC-NHC pincer complex

Theoretical, bottom m/z calcd for C33H36N5Pt+ (M + NCH3)+ 697.2616; Experimental, top
found 697.2452
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Figure A.9

HRMS of Pt CCC-NHC pincer complex

Theoretical, bottom m/z calcd for C32H33N4Pt+ (M-Ligand)+ 668.2350; Experimental, top
found 668.2520
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Figure A.10

59

1

H NMR spectrum of 2

Figure A.11

60

C NMR spectrum of 2

13

Figure A.12
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1

H NMR spectrum of 3

Figure A.13

62

C NMR spectrum of 3
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Figure A.14
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1

H NMR spectrum of 4

Figure A.15
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C NMR spectrum of 4
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Figure A.16
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1

H NMR spectrum of 6

Figure A.17
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C NMR spectrum of 6
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Figure A.18
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1

H NMR spectrum of 7

Figure A.19

68

C NMR spectrum of 7

13

Figure A.20

69

1

H NMR spectrum of 8

Figure A.21
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C NMR spectrum of 8
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Figure A.22
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1

H NMR spectrum of 9

Figure A.23
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C NMR spectrum of 9

13

Figure A.24
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1

H NMR spectrum of Zr CCC-NHC pincer complex

Figure A.25
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C NMR spectrum of Zr CCC-NHC pincer complex
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Figure A.26
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1

H NMR spectrum of Pt CCC-NHC pincer complex

Figure A.27
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C NMR spectrum of Pt CCC-NHC pincer complex
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SPECTROSCOPIC DATA FOR CHAPTER III COMPOUNDS
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Figure B.1
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1

H NMR spectrum of 2

Figure B.2
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C NMR spectrum of 2
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Figure B.3
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1

H NMR spectrum of 3

Figure B.4
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C NMR spectrum of 3
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Figure B.5
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1

H NMR spectrum of 5

Figure B.6
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C NMR spectrum of 5
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Figure B.7
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H NMR spectrum of 6

Figure B.8
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C NMR spectrum of 6
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Figure B.9
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H NMR spectrum of 7

Figure B.10

87

C NMR spectrum of 7
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Figure B.11
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H NMR spectrum of 8

Figure B.12
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C NMR spectrum of 8
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Figure B.13
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H NMR spectrum of 9

Figure B.14
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C NMR spectrum of 9
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Figure B.15
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1

H NMR spectrum of 10

Figure B.16
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C NMR spectrum of 10
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Figure B.17
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1

H NMR spectrum of 11

Table B.2
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C NMR spectrum of 11
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Figure B.18
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1

H NMR spectrum of 12

Figure B.19
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C NMR spectrum of 12
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